Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

The Xylazine Scourge Widens

by July 17, 2024
July 17, 2024
The Xylazine Scourge Widens

Jeffrey A. Singer

Millennium Health, a drug testing company that monitors drug use for pain management and drug addiction treatment centers, publishes “Signals Reports” on emerging drug use trends based on urine drug test samples across the country. In September 2023, the Millenium Signals Report revealed their labs detected the veterinary tranquilizer xylazine, which drug trafficking organizations mix with fentanyl to enhance its potency (users call it “tranq”), in all regions of the country but most heavily concentrated in the eastern US.

The report found that people who tested positive for fentanyl plus xylazine were more likely to use multiple other substances as well, including cocaine, methamphetamine, heroin, and diverted prescription pain pills.

On July 16, Millenium Health published a “Signals Alert” warning that the xylazine scourge has picked up steam in western states. The report states that since the White House Office of National Drug Control Policy (ONDCP) declared xylazine an emerging threat in April 2023, “the greatest gains in xylazine use were largely in the western half of the US; the Pacific, Mountain, and West North Central Census Divisions all increased significantly; New England also increased significantly.”

However, xylazine-positive urine tests remain highest in the East, with positive test rates there nearly twice the national average, at 15.6 percent. Rates were highest in Pennsylvania, New York, and Ohio.

Congress has not yet required the Drug Enforcement Administration to add xylazine to its schedule of controlled substances. However, soon after the ONDCP declared xylazine a threat in 2023, multiple states responded to the spread of xylazine by designating the tranquilizer a Schedule III controlled substance. Schedule III drugs are medically used drugs with a “moderate to low potential for physical and psychological dependence.”

Examples of Schedule III drugs include ketamine, codeine, and anabolic steroids. But this will do nothing to stop drug trafficking organizations from adding xylazine to fentanyl and other opioids they smuggle. Heroin, MDMA (“ecstasy” or “molly”), “magic mushrooms,” and cannabis have been Schedule I (“no currently accepted medical use and high potential for abuse”) for decades; methamphetamine and cocaine have been Schedule II (medically useful but “with a high potential for abuse”). That hasn’t stopped drug traffickers from providing any of those drugs to people seeking to buy them.

As I explained in the past, the “iron law of prohibition”—the harder the enforcement, the harder the drugs—drives xylazine’s emergence. Intensified law enforcement incentivizes drug trafficking organizations to develop more potent drugs that are easier to smuggle in smaller sizes and that they can subdivide into more units to sell. Because of the iron law, policymakers should beware: if they erect too many obstacles to xylazine smuggling, they will motivate drug trafficking organizations to substitute xylazine with something more potent and, therefore, easier to smuggle in smaller packages.

Another more powerful tranquilizer, medetomidine, used in both veterinary and human medicine, is already appearing on the black market. Drug toxicology labs in Maryland discovered medetomidine and its isomer dexmedetomidine (brand names Domitor and Precedex, respectively) in drug test samples in 2022. They have since been detected in Florida, Ohio, Pennsylvania, and Canada toxicology studies. These drugs are similar to xylazine but much more potent.

Like a broken record, policymakers continue the futile war on drugs, which brings newer and more potent drugs into the black market. Then, they double down on the drug war, further fueling the cycle. This pattern repeats endlessly. Until policymakers lift the metaphorical phonograph needle from the stuck groove by ending the drug war, they will keep playing this sad tune over and over.

0
FacebookTwitterGoogle +Pinterest
previous post
Starmer’s vision for Britain: key pledges and missing pieces from the King’s Speech
next post
Biden says his mental acuity is ‘pretty damn good,’ despite polls showing majority of Americans disagreeing

You may also like

Islam and Human Rights: Remarks at the Princeton...

December 15, 2023

Could the Latest TikTok “Ban” Pass Constitutional Muster?

March 12, 2024

Biden Administration Proposes Tightening Protectionist Buy American Act

November 6, 2024

126 Parole Orders over 7 Decades: A Historical Review of...

July 17, 2023

Friday Feature: Innovation School

June 13, 2025

Tennessee Becomes the Latest State to Remove Barriers...

May 18, 2023

Don’t Expand the Border Wall. Instead, Fix Existing...

November 2, 2023

Closing the Primary Care Gap

August 7, 2025

State Department’s Human Rights Reports and Their Failures

April 20, 2023

Trump Orders Review of Federal Second Amendment Policies

February 10, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • National Wealth Fund commits £200m to UK battery storage push

      August 28, 2025
    • XRP price prediction hits new highs, GMO Miner helps you earn $6,800 a day

      August 28, 2025
    • West End retailers lose £310m from VAT-free shopping ban in first half of year

      August 28, 2025
    • Dollar slips as Trump moves to sack Fed governor Lisa Cook in unprecedented clash over central bank independence

      August 28, 2025
    • CDC Director Susan Monarez refuses to be fired as other officials call it quits

      August 28, 2025
    • Bill Gates met with Trump to talk ‘importance of US global health programs and health research’: spox

      August 28, 2025

    Categories

    • Business (8,901)
    • Investing (2,246)
    • Politics (16,503)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved